Axxcess Wealth Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-12,918
Closed -$195K – 942
2024
Q1
$195K Sell
12,918
-1,861
-13% -$33.8K 0.01% 826
2023
Q4
$318K Sell
14,779
-106
-0.7% -$1.96K 0.01% 629
2023
Q3
$277K Buy
14,885
+414
+3% +$9.66K 0.01% 623
2023
Q2
$366K Buy
14,471
+644
+5% +$16.2K 0.03% 410
2023
Q1
$358K Buy
13,827
+574
+4% +$15.4K 0.03% 443
2022
Q4
$313K Sell
13,253
-7,882
-37% -$213K 0.03% 434
2022
Q3
$536K Sell
21,135
-815
-4% -$28.6K 0.05% 307
2022
Q2
$729K Buy
21,950
+1,788
+9% +$75.9K 0.07% 235
2022
Q1
$1.45M Sell
20,162
-839
-4% -$60.4K 0.11% 149
2021
Q4
$1.93M Buy
+21,001
New +$2.51M 0.14% 126

Other funds holding TDOC

Axxcess Wealth Management's TDOC Position: Q2 2024 in Review

Axxcess Wealth Management sold out of Teladoc Health (TDOC) in Q2 2024, closing a stake of 12,918 shares — an estimated $195K sold.

Axxcess Wealth Management first reported a position in TDOC in Q4 2021 and held it in 10 quarters. The position peaked at $1.93M in Q4 2021. 407 funds tracked by Wall St. Rank hold TDOC as of Q2 2024.

  • Axxcess Wealth Management reported no remaining Teladoc Health position as of Q2 2024 after selling out during the quarter.
  • Axxcess Wealth Management sold 12,918 Teladoc Health shares in Q2 2024, an estimated $195K.
  • Axxcess Wealth Management first reported a position in Teladoc Health in Q4 2021 and held it in 10 quarters.
  • Axxcess Wealth Management's Teladoc Health position peaked at $1.93M in Q4 2021.
  • 407 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2024.

Based on Axxcess Wealth Management's 13F filing for Q2 2024, filed 9 Aug 2024.